Avaliação de Prejuízo Cognitivo em Sobreviventes de Câncer de Mama: Estudo Transversal

Chemobrain em Câncer de Mama

Autores

DOI:

https://doi.org/10.1590/0102.3772e38218.pt

Palavras-chave:

Disfunção cognitiva, Sobreviventes, Câncer de mama, Psico-Oncologia

Resumo

Estudo prospectivo e transversal, para determinar a prevalência de prejuízo cognitivo decorrente da quimioterapia e explorar fatores preditores e mediadores em sobreviventes de câncer de mama. Utilizou-se o Termômetro de Distress, Escala de Ansiedade e Depressão, Functional Assessment of Chronic Illness Therapy-General e Cognitive Function. As sobreviventes (N = 62) reportaram uma alta prevalência de distress (46,8%) e de ansiedade (24,2%), com baixos escores nas subescalas déficit cognitivo e habilidades cognitivas percebidos. O funcionamento cognitivo esteve associado à idade (B = 1,42; p = 0,002), atuação profissional (B = -23,12; p = 0,004), depressão (B = -5,43; p = 0,001) e qualidade de vida (B = 1,24; p = 0,001). Prejuízo cognitivo deve ser considerado no serviço de Psico-Oncologia

Downloads

Não há dados estatísticos.

Biografia do Autor

Renata Nunes Pedras, Universidade Federal de São Paulo

Especialista em Psicologia Hospitalar (Área: Reabilitação Física) pela Universidade de São Paulo (USP), Especialista em Psicologia da Saúde pelo Programa de residência multiprofissional em Oncologia (Área: Psico-Oncologia) da Universidade Federal de São Paulo (UNIFESP).

Maria Fernanda Marcusso Manhães, Universidade Federal de São Paulo

Especialista em Psicologia da Saúde pelo Programa de residência multiprofissional em Oncologia (Área: Psico-Oncologia) da Universidade Federal de São Paulo (UNIFESP).

Aline Millani Carneiro, Universidade Federal de São Paulo

Mestre em Psicobiologia pela Universidade Federal de São Paulo (UNIFESP).

Getúlio Yuzo Okuma, Universidade Federal de São Paulo

Especialista em Psicologia da Saúde pelo Programa de residência multiprofissional em Oncologia (Área: Psico-Oncologia) da Universidade Federal de São Paulo (UNIFESP).

Simone Elias, Universidade Federal de São Paulo

Doutora em Ciências da Saúde e Pós-Doutora pela Universidade Federal de São Paulo (UNIFESP),  é Professora Adjunta da Escola Paulista de Medicina (EPM), Departamento de Ginecologia, UNIFESP.

Edvane Birelo Lopes De Domenico, Universidade Federal de São Paulo

Doutora em Enfermagem pela Universidade de São Paulo (USP), é Professora Adjunta da Escola Paulista de Enfermagem (EPE), Departamento de Enfermagem Clínica e Cirúrgica, Universidade Federal de São Paulo (UNIFESP) e Tutora/Preceptora em Enfermagem da Residência Multiprofissional em Oncologia na UNIFESP.

Cristiane Decat Bergerot, Universidade Federal de São Paulo

Doutora em Psicologia da Saúde pela Universidade de Brasília (UnB), Pós-Doutorado pela Universidade
Feredal de São Paulo (UNIFESP) e Pós-doutorado pelo City of Hope Comprehensive Cancer Center. É tutora/preceptora em Psico-Oncologia da Residência Multiprofissional em Oncologia da Universidade Federal de São Paulo.

Referências

Ahles, T. A., & Hurria, A. (2018). Cognition and cancer: conceptual and methodological issues and future directions. Psycho-Oncology, 27(1), 3-9. https://doi.org/10.1002/pon.4564

Arnold, B. J., Eremenco, S., Chang, C. H., Odom, L., Ribaudo, J., & Cella, D. (2000). Development of a single Portuguese language version of the functional assessment of cancer therapy general (FACT-G) scale. Quality of Life Research, 9(3), 316.

Avis, N. E., Levine, B. J., Case, L. D., Naftalis, E. Z., & Zee, K. J. van. (2015). Trajectories of depressive symptoms following breast cancer diagnosis. Cancer Epidemiology, Biomarkers & Prevention”¯: A Publication of the American Association for Cancer Research, 24(11), 1789-1795. https://doi.org/10.1158/1055-9965.EPI-15-0327

Bergerot, C. D., & Araujo, T. C. C. F. (2014). Assessment of distress and quality of life of cancer patients over the course of chemotherapy. Investigacion Y Educacion En Enfermeria, 32(2), 216-224. https://doi.org/10.1590/S0120-53072014000200004

Botega, N. J., Bio, M. R., Zomignani, M. A., Garcia, C., Jr., & Pereira, W. A. B. (1995). Mood disorders among medical in-patients: a validation study of the hospital anxiety and depression scale (HAD). Revista de Saúde Pública, 29(5), 355-363. https://doi.org/10.1590/S0034-89101995000500004

Boykoff, N., Moieni, M., & Subramanian, S. K. (2009). Confronting chemobrain: An in-depth look at survivors’ reports of impact on work, social networks, and health care response. Journal of Cancer Survivorship, 3(4), 223-232. https://doi.org/10.1007/s11764-009-0098-x

Bray, V. J., Dhillon, H. M., Bell, M. L., Kabourakis, M., Fiero, M. H., Yip, D., ... Vardy, J. L. (2017). Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy. Journal of Clinical Oncology, 35(2), 217-225. https://doi.org/10.1200/JCO.2016.67.8201

Brucker, P. S., Yost, K., Cashy, J., Webster, K., & Cella, D. (2005). General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Evaluation & The Health Professions, 28(2), 192-211. https://doi.org/10.1177/0163278705275341

Brunault, P., Champagne, A. L., Huguet, G., Suzanne, I., Senon, J. L., Body, G., ... Camus, V. (2016). Major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patients. Psycho-Oncology, 25(5), 513-520. https://doi.org/10.1002/pon.3947

Bultz, B. D., Groff, S. L., Fitch, M., Blais, M. C., Howes, J., Levy, K., & Mayer, C. (2011). Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psycho-Oncology, 20(5), 463-469. https://doi.org/10.1002/pon.1932

DeRuiter, M. B., Reneman, L., Boogerd,W., Veltman, D. J., Dam, F. S. van, Nederveen, A. J., ... Schagen, S. B. (2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32(8), 1206-1219. https://doi.org/10.1002/hbm.21102

Decat, C. S., Laros, J. A., & Araujo, T. C. C. F. (2009). Distress Thermometer: validation of a brief screening instrument to detect distress in oncology patients. Psico-USF, 14(3), 253-260. https://doi.org/10.1590/S1413-82712009000300002

Fallowfield, L., & Jenkins, V. (2015). Psychosocial/Survivorship issues in breast cancer: are we doing better? Journal of the National Cancer Institute, 107(1), 335. https://doi.org/10.1093/jnci/dju335

Ferguson, R. J., McDonald, B. C., Rocque, M. A., Furstenberg, C. T., Horrigan, S., Ahles, T. A., & Saykin, A. J. (2012). Development of CBT for chemotherapy-related cognitive change: Results of a waitlist control trial. Psycho-Oncology, 21(2), 176-186. https://doi.org/10.1002/pon.1878

Hartman, S. J., Nelson, S. H., Myers, E., Natarajan, L., Sears, D. D., Palmer, B. W. ... Patterson, R. E. (2018). Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study. Cancer, 124(1), 192-202. https://doi.org/ 10.1002/cncr.30987

Hayes, A. F. (2013). Introduction to mediation, moderation, and conditional process analysis. New York: Guilford Press.

Hurria, A., Somlo, G., & Ahles, T. (2007) Renaming "chemobrain". Cancer Investigation, 25, 373”“377. https://doi.org/10.1080/07357900701506672

International Agency for Research on Cancer (2018). GLOBOCAN 2018: Estimated cancer incidence, mortality and prevalence worldwide in 2018. Recuperado em janeiro 13, 2020, de https://www.uicc.org/news/new-global-cancer-data-globocan-2018

Janelsins, M. C., Heckler, C. E., Peppone, L. J., Kamen, C., Mustian, K. M., Mohile, S. G., ... Morrow, G. R. (2017). Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: An analysis from a nationwide, multicenter, prospective longitudinal study. Journal of Clinical Oncology, 35(5), 506-514. https://doi.org/10.1200/JCO.2016.68.5826

Krebber, A. M. H., Buffart, L. M., Kleijn, G., Riepma, I. C., DeBree, R., Leemans, C. R., ... Verdonck-de Leeuw, I. M. (2014). Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-Oncology, 23(2), 121-130. https://doi.org/10.1002/pon.3409

Lange, M., Joly, F., Vardy, J., Ahles, T., Dubois, M., Tron, L., … Castel, H. (2019). Cancer-related cognitive impairment: An update on state of the art, detection, and management strategies in cancer survivors. Annals of Oncology, 30(12), 1925-1940. https://doi.org/10.1093/annonc/mdz410

Myers, J. S., Pierce, J., & Pazdernik, T. (2008). Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier and cognitive impairment. Oncology Nursing Forum, 35(6), 916-920. https://doi.org/10.1188/08.ONF.916-920

Mitchell, A. J., Ferguson, D. W., Gill, J., Paul, J., & Symonds, P. (2013). Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: A systematic review and meta-analysis. Lancet Oncology, 14(8), 721-732. https://doi.org/10.1016/S1470-2045(13)70244-4

Morean, D. F., & Cherney, L. R. (2016). Screening for Cognitive Impairment Associated with Chemotherapy for Breast Cancer. Current Breast Cancer Reports, 8, 151-157. https://doi.org/10.1007/s12609-016-0219-2

Neuwelt, E. A., Bauer, B., Fahlke, C., Fricker, G., Iadecola, C., Janigro, D., ... Drewes, L. R. (2011). Engaging neuroscience to advance translational research in brain barrier biology. Nature Reviews Neuroscience, 12(3), 169-182. https://doi.org/10.1038/nrn2995

Ongnok, B., Chattipakorn, N., & Chattipakorn, S. C. (2019). Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions. Experimental Neurology, 324, 113118. https://doi.org/10.1016/j.expneurol.2019.113118

Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., ... Ganz, P. A. (2016). American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA: A Cancer Journal for Clinicians, 66(1), 43-73. https://doi.org/10.3322/caac.21319

Saboonchi, F., Petersson, L. M., Wennman-Larsen, A., Alexanderson, K., & Vaez, M. (2015). Trajectories of anxiety among women with breast cancer: A proxy for adjustment from acute to transitional survivorship. Journal of Psychosocial Oncology, 33(6), 603-619. https://doi.org/10.1080/07347332.2015.1082165

Siegel, R. L., Miller, K. D., Jemal, A. (2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69(1), 7-34. https://doi.org/10.3322/caac.21551

Small, B. J., Jim, H. S. L., Eisel, S. L., Jacobsen, P. B., Scott, S. B. (2019). Cognitive performance of breast cancer survivors in daily life: Role of fatigue and depressed mood. Psycho-oncology, 28(11), 2174-2180. https://doi.org/10.1002/pon.5203

Vardy, J. L., Stouten-Kemperman, M. M., Pond, G., Booth, C. M., Rourke, S. B., Dhillon, H. M., ... Tannock, I. F. (2017). A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer. Brain Imaging and Behavior, 1-12. https://doi.org/10.1007/s11682-017-9728-5

Wagner, L. I., Sweet, J., Butt, Z., Lai, J., & Cella, D. (2009). Measuring Patient Self-Reported Cognitive Function: Development of the Functional Assessment of Cancer Therapy”“Cognitive Function Instrument. The Journal of Supportive Oncology, 7(6), W32-W39.

Wang, X.-M., Walitt, B., Saligan, L., Tiwari, A. F., Cheung, C. W., & Zhang, Z.-J. (2015). Chemobrain: A critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy. Cytokine, 72(1), 86”“96. https://doi.org/10.1016/j.cyto.2014.12.006

Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010). Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer, 116(14), 3348-3356. https://doi.org/10.1002/cncr.25098

World Health Organization (2016). Breast cancer: Prevention and control. Recuperado em novembro 15, 2017, de http://www.who.int/cancer/detection/breastcancer/en/

Zimmer, P., Baumann, F. T., Oberste, M., Wright, P., Garthe, A., Schenk, A., ... Wolf, F. (2016). Effects of exercise interventions and physical activity behavior on cancer related cognitive impairments: A systematic review. BioMed Research International, 2016, 1820954. https://doi.org/ 10.1155/2016/1820954

Publicado

2022-10-24

Como Citar

Pedras, R. N., Manhães, M. F. M., Carneiro, A. M., Okuma, G. Y., Elias, S., De Domenico, E. B. L., & Bergerot, C. D. (2022). Avaliação de Prejuízo Cognitivo em Sobreviventes de Câncer de Mama: Estudo Transversal: Chemobrain em Câncer de Mama. Psicologia: Teoria E Pesquisa, 38. https://doi.org/10.1590/0102.3772e38218.pt

Edição

Seção

Estudos Empíricos